Get Updates
Get notified of breaking news, exclusive insights, and must-see stories!

Sun Pharma commercially launches Amifostine

New Delhi, Mar 31 (UNI) Sun Pharmaceutical Industries Ltd today said it has commercially launched generic Amifostine for Injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyol.

The company's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories, said a statement.

The firm had received a USFDA approval for this earlier in March 2008.

Ethyoi has annual sales of approximately 80 million dollars in the US.

Sun Pharma, being the first-to-file an ANDA for generic Ethyol, has a 180-day marketing exclusivity.

UNI PBB SR DS1145

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+